Rational design of novel benzisoxazole derivatives with acetylcholinesterase inhibitory and serotoninergic 5-HT(4) receptors activities for the treatment of Alzheimer’s disease

A rigidification strategy was applied to the preclinical candidate donecopride, an acetylcholinesterase inhibitor possessing 5-HT(4)R agonist activity. Inspired by promising bioactive benzisoxazole compounds, we have conducted a pharmacomodulation study to generate a novel series of multitarget dire...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Sci Rep
Hlavní autoři: Lalut, Julien, Payan, Hugo, Davis, Audrey, Lecoutey, Cédric, Legay, Rémi, Sopkova-de Oliveira Santos, Jana, Claeysen, Sylvie, Dallemagne, Patrick, Rochais, Christophe
Médium: Artigo
Jazyk:Inglês
Vydáno: Nature Publishing Group UK 2020
Témata:
Article
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC7033111/
https://ncbi.nlm.nih.gov/pubmed/32080261
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/s41598-020-59805-7
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky